MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-12-0015845
Dr. Ars India Labs Private Limited
Dr. Ars India Labs Private Limited - pharma in Madurai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.11 Cr
▼ 1% YoY
Net profit · FY 2025
₹83,606
Net margin 0.8%
EBITDA · FY 2025
₹8.1 Lakh
EBITDA margin 7.3%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹74 Lakh
Satisfied ₹36 Lakh
Company age
23 yrs
Est. 2003
Directors on board
2
As per MCA filings
About Dr. Ars India Labs Private Limited
Data last updated:
Dr. Ars India Labs Private Limited is a private limited company based in Madurai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 May 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24239TN2003PTC050810. Its GSTIN is 33AACCD7074Q1Z7 (Tamil Nadu).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajmeerkhan Mohamed and Kalanjiyam Hakkim.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 311 – B Kabir Nagar Main Road Masthanpatti Madurai, Tamil Nadu, India – 625020.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹83,606 (net margin 0.8%) and EBITDA of ₹8.1 Lakh (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 43% over five years.
As per MCA filings, the company has open charges of ₹74 Lakh and satisfied charges of ₹36 Lakh on record.
Dr. Ars India Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-12-0015845). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239TN2003PTC050810
Registration Number 050810
Incorporation Date 02 May 2003
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-12-0015845
Recognitions & Rankings of Dr. Ars India Labs
Contact details
Dr. Ars India Labs Private Limited's registered office is in Madurai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address311 – B Kabir Nagar Main Road Masthanpatti Madurai, Tamil Nadu, India – 625020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dr. Ars India Labs Private Limited, buy the company report.
Comprehensive company report
Dr. Ars India Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dr. Ars India Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dr. Ars India Labs Private Limited, buy the company report.
Financials of Dr. Ars India Labs Private Limited
FY 2025 filings availableDr. Ars India Labs Private Limited reported revenue of ₹1.11 Cr (down 1% YoY) for FY 2025.
Revenue · FY 2025
₹1.11 Cr ▼ 1%
Net profit · FY 2025
₹83,606 margin 0.8%
EBITDA · FY 2025
₹8.1 Lakh margin 7.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 7%
5 years · compounded
▲ 43%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▼ 3%
5 years · compounded
▲ 1%
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 43%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83,606 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr. Ars India Labs Private Limited, buy the company report.
Board of directors of Dr. Ars India Labs Private Limited
Dr. Ars India Labs has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajmeerkhan Mohamed | Director | 24 Jul 2015 | 11 Years 3 Months | Current |
| Kalanjiyam Hakkim | Director | 24 Jul 2015 | 11 Years 3 Months | Current |
Auditor
Dr. Ars India Labs Private Limited is audited by Skandaraja K for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Skandaraja K | FY 2023 | 243660 |
Shareholding
The shareholding of Dr. Ars India Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dr. Ars India Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹74 Lakh
Satisfied charges
₹36 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2021 | 100517612 | Canara Bank | ₹45 Lakh | Open | |
| 23 Aug 2021 | 100476368 | Canara Bank | ₹4 Lakh | Open | |
| 19 May 2016 | 100047692 | Canara Bank | ₹20 Lakh | Open | |
| 17 Dec 2015 | 10618747 | Syndicate Bank | ₹5 Lakh | Open | |
| 30 Mar 2006 | 90325484 | Indianm Oveseas Bank | ₹36 Lakh | Satisfied |
To see the full charge records of Dr. Ars India Labs Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Dr. Ars India Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr. Ars India Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dr. Ars India Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCD7074Q1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dr. Ars India Labs Private Limited, buy the company report.
Recent activity
Dr. Ars India Labs Private Limited has 9 board changes on record since 2007: 2 appointments and 7 cessations. The latest: Meera Hussain Syed ceased to be Director on 20 Oct 2018.
AGM
Dr. Ars India Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dr. Ars India Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Canara Bank amounted to Rs. 45.00 Lakh with Charge ID 100517612 was registered on 27 Dec 2021.
Charges
A charge with Canara Bank amounted to Rs. 4.00 Lakh with Charge ID 100476368 was registered on 23 Aug 2021.
Charges
A charge with Canara Bank of Rs. 20.00 Lakh registered on 19 May 2016 with Charge ID 100047692 was modified on 23 Aug 2021.
Ceased
Meera Hussain Syed ceased to be Director.
Ceased
Ajmeerkhan Mohamed ceased to be Additional Director.
Ceased
Kalanjiyam Hakkim ceased to be Additional Director.
Charges
A charge with Canara Bank amounted to Rs. 20.00 Lakh with Charge ID 100047692 was registered on 19 May 2016.
Charges
A charge with Syndicate Bank amounted to Rs. 5.00 Lakh with Charge ID 10618747 was registered on 17 Dec 2015.
Ceased
Kadharshah Muthalif ceased to be Additional Director.
Appointed
Ajmeerkhan Mohamed was appointed as Director.
7 earlier events are in the company report.
Frequently asked questions
Dr. Ars India Labs is an active private limited company based in Madurai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 May 2003 (23+ years old) and is registered under CIN U24239TN2003PTC050810.
Dr. Ars India Labs has 2 current directors:
- Ajmeerkhan Mohamed - Director
- Kalanjiyam Hakkim - Director
The latest financial statements of Dr. Ars India Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr. Ars India Labs is 33AACCD7074Q1Z7, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Dr. Ars India Labs is U24239TN2003PTC050810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Ars India Labs was incorporated on 02 May 2003, making it 23+ years old. It is registered with the Registrar of Companies, Chennai.
Meera Hussain Syed ceased to be Director on 20 Oct 2018. Ajmeerkhan Mohamed ceased to be Additional Director on 10 Sep 2016. Kalanjiyam Hakkim ceased to be Additional Director on 10 Sep 2016. Dr. Ars India Labs has 9 board changes on record in total.
Yes, Dr. Ars India Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-12-0015845).
The registered office of Dr. Ars India Labs is at 311 – B Kabir Nagar Main Road Masthanpatti Madurai, Tamil Nadu, India – 625020.
Dr. Ars India Labs operates in the pharma industry, in the drug formulation and development segment.